Lupus nephritis: Enigmas, conflicting models and an emerging concept

Molecular Medicine

Volumn 19, Issue 1, 2013, Pages 161-169

  Seredkina, Natalya ^a   van der Vlag, Johan ^b   Berden, Jo ^b   Mortensen, Elin ^a   Rekvig, Ole Petter ^a  

^a UNIVERSITY OF TROMSØ   (Norway)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYRIBONUCLEASE I; DOUBLE STRANDED DNA ANTIBODY; HISTONE ANTIBODY; IMMUNOGLOBULIN G; NUCLEOSOME ANTIBODY;

ANTIBODY PRODUCTION; ARTICLE; CHROMATIN; CROSS REACTION; DNA FRAGMENTATION; DNASEI GENE; DOWN REGULATION; GENE SILENCING; GLOMERULUS; GLOMERULUS BASEMENT MEMBRANE; HUMAN; IMMUNE COMPLEX DEPOSITION; IMMUNE COMPLEX NEPHRITIS; INFLAMMATION; LUPUS ERYTHEMATOSUS NEPHRITIS; MESANGIUM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANTIBODIES, ANTINUCLEAR; CHROMATIN; DEOXYRIBONUCLEASE I; HUMANS; LUPUS NEPHRITIS;

EID: 84887059952     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/molmed.2013.00010     Document Type: Article

References (100)

1. Ceppellini R, Polli E, Celada F. (1957) A DNA-reacting factor in serum of a patient with lupus erythematosus diffusus. Proc. Soc. Exp. Biol. Med. 96:572-4.
2. Robbins WC, Holman HR, Deicher H, Kungel HG. (1957) Complement fixation with cell nuclei and DNA in lupus erythematosus. Proc. Soc. Exp. Biol. Med. 96:575-9.
3. Seligmann M. (1957) Demonstration in the blood of patients with disseminated lupus erythematosus a substance determining a precipitation reaction with desoxyribonucleic acid [in French]. C. R. Hebd. Seances Acad. Sci. 245:243-5.
4. Miescher P, Strassle R. (1957) New serological methods for the detection of the L.E. factor. Vox Sang 2:283-7.
5. Izui S, Lambert PH, Fournie GJ, Turler H, Miescher PA. (1977) Features of systemic lupus erythematosus in mice injected with bacterial lipopolysaccharides: identificantion of circulating DNA and renal localization of DNA-anti-DNA complexes. J. Exp. Med. 145:1115-30.
6. Izui S, Lambert PH, Miescher PA. (1976) In vitro demonstration of a particular affinity of glomerular basement membrane and collagen for DNA: a possible basis for a local formation of DNA-anti-DNA complexes in systemic lupus erythematosus. J. Exp. Med. 144:428-43.
7. Khalil M, Spatz L, Diamond B. (1999) Anti-DNA antibodies. In Systemic Lupus Erythematosus. Lahita RG, Ed. Academic Press, San Diego, CA, pp. 197-217.
8. Hahn BH. (1998) Antibodies to DNA. N. Engl. J. Med. 338:1359-68.
9. Xie C, Liang Z, Chang S, Mohan C. (2003) Use of a novel elution regimen reveals the dominance of polyreactive antinuclear autoantibodies in lupus kidneys. Arthritis Rheum. 48:2343-52.
10. Kalaaji M, Sturfelt G, Mjelle JE, Nossent H, Rekvig OP. (2006) Critical comparative analyses of anti-alpha-actinin and glomerulus-bound antibodies in human and murine lupus nephritis. Arthritis Rheum. 54:914-26.
11. Van Bruggen MC, Kramers C, Hylkema MN, Smeenk RJ, Berden JH. (1996) Significance of anti-nuclear and anti-extracellular matrix autoantibodies for albuminuria in murine lupus nephritis; a longitudinal study on plasma and glomerular eluates in MRL/l mice. Clin. Exp. Immunol. 105:132-9.
12. Dang H, Harbeck RJ. (1984) The in vivo and in vitro glomerular deposition of isolated anti-double-stranded-DNA antibodies in NZB/W mice. Clin. Immunol. Immunopathol. 30:265-78.
13. Dang H, Harbeck RJ. (1982) A comparison of anti-DNA antibodies from serum and kidney eluates of NZB x NZW F1 mice. J. Clin. Lab. Immunol. 9:139-45.
14. Winfield JB, Faiferman I, Koffler D. (1977) Avidity of anti-DNA antibodies in serum and IgG glomerular eluates from patients with systemic lupus erythematosus: association of high avidity antinative DNA antibody with glomerulonephritis. J. Clin. Invest. 59:90-6.
15. Mortensen ES, Rekvig OP. (2009) Nephritogenic potential of anti-DNA antibodies against necrotic nucleosomes. J. Am. Soc. Nephrol. 20:696-704.
16. Jang YJ, Stollar BD. (2003) Anti-DNA antibodies: aspects of structure and pathogenicity. Cell. Mol. Life Sci. 60:309-20.
17. van der Vlag J, Berden JH. (2011) Lupus nephritis: role of antinucleosome autoantibodies. Semin. Nephrol. 31:376-89.
18. Munoz LE, et al. (2009) Remnants of secondarily necrotic cells fuel inflammation in systemic lupus erythematosus. Arthritis Rheum. 60:1733-42.
19. Kruse K, et al. (2010) Inefficient clearance of dying cells in patients with SLE: anti-dsDNA autoantibodies, MFG-E8, HMGB-1 and other players. Apoptosis. 15:1098-113
20. Licht R, Dieker JW, Jacobs CW, Tax WJ, Berden JH. (2004) Decreased phagocytosis of apoptotic cells in diseased SLE mice. J. Autoimmun. 22:139-45.
21. Weening JJ, et al. (2004) The classification of glomerulonephritis in systemic lupus erythematosus revisited. J. Am. Soc. Nephrol. 15:241-50.
22. Seredkina N, Zykova SN, Rekvig OP. (2009) Progression of murine lupus nephritis is linked to acquired renal Dnase1 deficiency and not to upregulated apoptosis. Am. J. Pathol. 175:97-106.
23. Seredkina S, Rekvig OP. (2011) Acquired loss of renal nuclease activity is restricted to DNaseI and is an organ-selective feature in murine lupus nephritis. Am. J. Pathol. 179:1120-8.
24. Fenton K, et al. (2009) Anti-dsDNA antibodies promote initiation, and acquired loss of renal Dnase1 promotes progression of lupus nephritis in autoimmune (NZBxNZW)F1 mice. PLoS One. 4:e8474.
25. Basnakian AG, et al. (2005) Cisplatin nephrotoxicity is mediated by deoxyribonuclease I. J. Am. Soc. Nephrol. 16:697-702.
26. Zykova SN, Seredkina N, Benjaminsen J, Rekvig OP. (2008) Reduced fragmentation of apoptotic chromatin is associated with nephritis in lupusprone (NZB x NZW)F(1) mice. Arthritis Rheum. 58:813-25.
27. Mostoslavsky G, et al. (2001) Lupus anti-DNA autoantibodies cross-react with a glomerular structural protein: a case for tissue injury by molecular mimicry. Eur. J. Immunol. 31:1221-7.
28. Zhao Z, et al. (2005) Cross-reactivity of human lupus anti-DNA antibodies with alpha-actinin and nephritogenic potential. Arthritis Rheum. 52:522-30.
29. Amital H, et al. (2005) Treatment with a lamininderived peptide suppresses lupus nephritis. J. Immunol. 175:5516-23.
30. Raz E, Ben Bassat H, Davidi T, Shlomai Z, Eilat D. (1993) Cross-reactions of anti-DNA autoantibodies with cell surface proteins. Eur. J. Immunol. 23:383-90.
31. D'Andrea DM, Coupaye Gerard B, Kleyman TR, Foster MH, Madaio MP. (1996) Lupus autoantibodies interact directly with distinct glomerular and vascular cell surface antigens. Kidney Int. 49:1214-21.
32. Krishnan MR, Wang C, Marion TN. (2012) Anti-DNA autoantibodies initiate experimental lupus nephritis by binding directly to the glomerular basement membrane in mice. Kidney Int. 82:184-92.
33. Manson JJ, et al. (2009) Relationship between anti-dsDNA, anti-nucleosome and anti-alphaactinin antibodies and markers of renal disease in patients with lupus nephritis: a prospective longitudinal study. Arthritis Res. Ther. 11:R154.
34. Kalaaji M, et al. (2007) Glomerular apoptotic nucleosomes are central target structures for nephritogenic antibodies in human SLE nephritis. Kidney Int. 71:664-72.
35. Kalaaji M, Mortensen E, Jorgensen L, Olsen R, Rekvig OP. (2006) Nephritogenic lupus antibodies recognize glomerular basement membraneassociated chromatin fragments released from apoptotic intraglomerular cells. Am. J. Pathol. 168:1779-92.
36. Schroeder K, Herrmann M, Winkler TH. (2013) The role of somatic hypermutation in the generation of pathogenic antibodies in SLE. Autoimmunity. 46:121-7.
37. Wellmann U, et al. (2005) The evolution of human anti-double-stranded DNA autoantibodies. Proc. Natl. Acad. Sci. U. S. A. 102:9258-63.
38. Murphy K. (2011) Janeway's Immunobiology. Garland Science, New York. Chapter 4, Antigen Recognition by B-cell and T-cell Receptors; pp. 127-156; Chapter 5, The Generation of Lymphocyte Antigen Receptors; pp. 157-200; Chapter 10, The Humoral Immune Response; pp. 387-428.
39. Starke C, et al. (2011) High frequency of autoantibody-secreting cells and long-lived plasma cells within inflamed kidneys of NZB/W F1 lupus mice. Eur. J. Immunol. 41:2107-12.
40. Radic M, Herrmann M, van der Vlag J, Rekvig OP. (2011) Regulatory and pathogenetic mechanisms of autoantibodies in SLE. Autoimmunity 44:349-56.
41. Xu H, Li H, Suri-Payer E, Hardy RR, Weigert M. (1998) Regulation of anti-DNA B cells in recombination-activating gene-deficient mice. J. Exp. Med. 188:1247-54.
42. Chen C, et al. (1994) Deletion and editing of B cells that express antibodies to DNA. J. Immunol. 152:1970-82.
43. Marion TN, Krishnan MR, Desai DD, Jou NT, Tillman DM. (1997) Monoclonal anti-DNA antibodies: structure, specificity, and biology. Methods. 11:3-11.
44. Carroll P, Stafford D, Schwartz RS, Stollar BD. (1985) Murine monoclonal anti-DNA autoantibodies bind to endogenous bacteria. J. Immunol. 135:1086-90.
45. Shoenfeld Y, et al. (1983) Polyspecificity of monoclonal lupus autoantibodies produced by humanhuman hybridomas. N. Engl. J. Med. 308:414-20.
46. Andrzejewski C Jr, Rauch J, Lafer E, Stollar BD, Schwartz RS. (1981) Antigen-binding diversity and idiotypic cross-reactions among hybridoma autoantibodies to DNA. J. Immunol. 126:226-31.
47. Lafer EM, et al. (1981) Polyspecific monoclonal lupus autoantibodies reactive with both polynucleotides and phospholipids. J. Exp. Med. 153:897-909.
48. van Bavel CC, Fenton KA, Rekvig OP, van der Vlag J, Berden JH. (2008) Glomerular targets of nephritogenic autoantibodies in systemic lupus erythematosus. Arthritis Rheum. 58:1892-9.
49. Shlomchik M, et al. (1990) Anti-DNA antibodies from autoimmune mice arise by clonal expansion and somatic mutation. J. Exp. Med. 171:265-92.
50. Marion TN, Krishnan MR, Steeves MA, Desai DD. (2003) Affinity maturation and autoimmunity to DNA. Curr. Dir. Autoimmun. 6:123-53.
51. Chan OT, Hannum LG, Haberman AM, Madaio MP, Shlomchik MJ. (1999) A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus. J. Exp. Med. 189:1639-48.
52. Li S, Holdsworth SR, Tipping PG. (1997) Antibody independent crescentic glomerulonephritis in mu chain deficient mice. Kidney Int. 51:672-8.
53. Waters ST, et al. (2004) Breaking tolerance to double stranded DNA, nucleosome, and other nuclear antigens is not required for the pathogenesis of lupus glomerulonephritis. J. Exp. Med. 199:255-64.
54. Rovin BH, et al. (2012) Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the Lupus Nephritis Assessment with Rituximab study. Arthritis Rheum. 64:1215-26.
55. Ehrenstein MR, et al. (1995) Human IgG anti-DNA antibodies deposit in kidneys and induce proteinuria in SCID mice. Kidney Int. 48:705-11.
56. Ravirajan CT, et al. (1998) Genetic, structural and functional properties of an IgG DNA-binding monoclonal antibody from a lupus patient with nephritis. Eur. J. Immunol. 28:339-50.
57. Choi J, Kim ST, Craft J. (2012) The pathogenesis of systemic lupus erythematosus: an update. Curr. Opin. Immunol. 24:651-7.
58. Zykova SN, Tveita AA, Rekvig OP. (2010) Renal Dnase1 enzyme activity and protein expression is selectively shut down in murine and human membranoproliferative lupus nephritis. PLoS One. 10:5.
59. Berden JH, Licht R, Van Bruggen MC, Tax WJ. (1999) Role of nucleosomes for induction and glomerular binding of autoantibodies in lupus nephritis. Curr. Opin. Nephrol. Hypertens. 8:299-306.
60. Van Bruggen MC, et al. (1997) Antigen specificity of anti-nuclear antibodies complexed to nucleosomes determines glomerular basement membrane binding in vivo. Eur. J. Immunol. 27:1564-9.
61. Samejima K, Earnshaw WC. (2005) Trashing the genome: the role of nucleases during apoptosis. Nat. Rev. Mol. Cell. Biol. 6:677-88.
62. Kawane K, Nagata S. (2008) Nucleases in programmed cell death. Methods Enzymol. 442:271-87.
63. Berden JH, Grootscholten C, Jurgen WC, van der Vlag J. (2002) Lupus nephritis: a nucleosome waste disposal defect? J. Nephrol. 15 Suppl 6: S1-10.
64. Macanovic M, et al. (1996) The treatment of systemic lupus erythematosus (SLE) in NZB/W F1 hybrid mice: studies with recombinant murine DNase and with dexamethasone. Clin. Exp. Immunol. 106:243-52.
65. Davis JC Jr, et al. (1999) Recombinant human Dnase I (rhDNase) in patients with lupus nephritis. Lupus. 8:68-76.
66. Verthelyi D, Dybdal N, Elias KA, Klinman DM. (1998) DNAse treatment does not improve the survival of lupus prone (NZB x NZW)F1 mice. Lupus. 7:223-30.
67. Napirei M, Ricken A, Eulitz D, Knoop H, Mannherz HG. (2004) Expression pattern of the deoxyribonuclease 1 gene: lessons from the Dnase1 knockout mouse. Biochem. J. 380:929-37.
68. Thiyagarajan D, et al. (2012) Silencing of renal DNaseI in murine lupus nephritis imposes exposure of large chromatin fragments and activation of toll like receptors and the Clec4e. PLoS One. 7:e34080.
69. Merrell MA, et al. (2006) Toll-like receptor 9 agonists promote cellular invasion by increasing matrix metalloproteinase activity. Mol. Cancer Res. 4:437-47.
70. Lim EJ, et al. (2006) Activation of toll-like receptor-9 induces matrix metalloproteinase-9 expression through Akt and tumor necrosis factoralpha signaling. FEBS Lett. 580:4533-8.
71. Han YP, Tuan TL, Wu H, Hughes M, Garner WL. (2001) TNF-alpha stimulates activation of pro-MMP2 in human skin through NF-(kappa)B mediated induction of MT1-MMP. J. Cell Sci. 114:131-9.
72. Ben DD, Reznick AZ, Srouji S, Livne E. (2008) Exposure to pro-inflammatory cytokines upregulates MMP-9 synthesis by mesenchymal stem cells-derived osteoprogenitors. Histochem. Cell. Biol. 129:589-97.
73. Triantafyllopoulou A, et al. (2010) Proliferative lesions and metalloproteinase activity in murine lupus nephritis mediated by type I interferons and macrophages. Proc. Natl. Acad. Sci. U. S. A. 107:3012-7.
74. Gaipl US, et al. (2006) Inefficient clearance of dying cells and autoreactivity. Curr. Top. Microbiol. Immunol. 305:161-76.
75. Brown GD. (2008) Sensing necrosis with Mincle. Nat. Immunol. 9:1099-100.
76. Yamasaki S, et al. (2008) Mincle is an ITAMcoupled activating receptor that senses damaged cells. Nat. Immunol. 9:1179-88.
77. Geijtenbeek TB, Gringhuis SI. (2009) Signalling through C-type lectin receptors: shaping immune responses. Nat. Rev. Immunol. 9:465-79.
78. Overall CM, Butler GS. (2007) Protease yoga: extreme flexibility of a matrix metalloproteinase. Structure. 15:1159-61.
79. Walport MJ. (2002) Complement and systemic lupus erythematosus. Arthritis Res. 4 Suppl 3: S279-93.
80. van Bavel CC, et al. (2011) Apoptosis-induced histone H3 methylation is targeted by autoantibodies in systemic lupus erythematosus. Ann. Rheum. Dis. 70:201-7.
81. Dieker JW, et al. (2007) Apoptosis-induced acetylation of histones is pathogenic in systemic lupus erythematosus. Arthritis Rheum. 56:1921-33.
82. Fransen JH, et al. (2009) Mouse dendritic cells matured by ingestion of apoptotic blebs induce T cells to produce interleukin-17. Arthritis Rheum. 60:2304-13.
83. Svejstrup JQ. (2013) RNA polymerase II transcript elongation. Biochim. Biophys. Acta. 1829:1.
84. Core LJ, Waterfall JJ, Lis JT. (2008) Nascent RNA sequencing reveals widespread pausing and divergent initiation at human promoters. Science. 322:1845-8.
85. Hobson DJ, Wei W, Steinmetz LM, Svejstrup JQ. (2012) RNA polymerase II collision interrupts convergent transcription. Mol. Cell. 48:365-74.
86. Kizer KO, et al. (2005) A novel domain in Set2 mediates RNA polymerase II interaction and couples histone H3 K36 methylation with transcript elongation. Mol. Cell. Biol. 25:3305-16.
87. Xiao T, et al. (2003) Phosphorylation of RNA polymerase II CTD regulates H3 methylation in yeast. Genes Dev. 17:654-63.
88. Shearwin KE, Callen BP, Egan JB. (2005) Transcriptional interference: a crash course. Trends Genet. 21:339-45.
89. Fismen S, et al. (2012) Impact of the tumor necrosis factor receptor-associated protein 1 (Trap1) on renal DNaseI shutdown and on progression of murine and human lupus nephritis. Am. J. Pathol. 182:688-700.
90. Munoz LE, Lauber K, Schiller M, Manfredi AA, Herrmann M. (2010) The role of defective clearance of apoptotic cells in systemic autoimmunity. Nat. Rev. Rheumatol. 6:280-9.
91. Dieker JW, van der Vlag J, Berden JH. (2004) Deranged removal of apoptotic cells: its role in the genesis of lupus. Nephrol. Dial. Transplant. 19:282-5.
92. Kaplan MJ. (2004) Apoptosis in systemic lupus erythematosus. Clin. Immunol. 112:210-8.
93. Al-Mayouf SM, et al. (2011) Loss-of-function variant in DNASE1L3 causes a familial form of systemic lupus erythematosus. Nat. Genet. 43:1186-8.
94. Baron WF, et al. (1998) Cloning and characterization of an actin-resistant DNase I-like endonuclease secreted by macrophages. Gene. 215:291-301.
95. Bendiksen S, et al. (2008) Glomerular expression of large polyomavirus T antigen in binary tetoff regulated transgenic mice induces apoptosis, release of chromatin and initiates a lupus-like nephritis. Mol. Immunol. 45:728-39.
96. Fenton KA, Mjelle JE, Jakobsen S, Olsen R, Rekvig OP. (2008) Renal expression of polyomavirus large T antigen is associated with nephritis in human systemic lupus erythematosus. Mol. Immunol. 45:3117-24.
97. Fishman JA. (2002) BK virus nephropathy: polyomavirus adding insult to injury. N. Engl. J. Med. 347:527-30.
98. Licht R, Van Bruggen MC, Oppers-Walgreen B, Rijke TP, Berden JH. (2001) Plasma levels of nucleosomes and nucleosome-autoantibody complexes in murine lupus: effects of disease progression and lipopolyssacharide administration. Arthritis Rheum. 44:1320-30.
99. Fismen S, et al. (2009) Circulating chromatinanti-chromatin antibody complexes bind with high affinity to dermo-epidermal structures in murine and human lupus nephritis. Lupus. 18:597-607.
100. Hedberg A, Fismen S, Fenton KA, Mortensen ES, Rekvig OP. (2010) Deposition of chromatin-IgG complexes in skin of nephritic MRL-lpr/lpr mice is associated with increased local matrix metalloprotease activities. Exp. Dermatol. 19:e265-74.